Breaking News
February 20, 2019 - Newly licensed nurses work for long hours, also have a second paid job
February 20, 2019 - Physicists identify simple mechanism used by deadly bacteria to fend off antibiotics
February 20, 2019 - FDA Grants Priority Review to Genentech’s Personalized Medicine Entrectinib
February 20, 2019 - Exposure to chemicals before and after birth is associated with a decrease in lung function
February 20, 2019 - Neuroscientists reveal that simple brain region can guide complex feats of mental activity
February 20, 2019 - Study finds new link between food allergies and multiple sclerosis
February 20, 2019 - First gene therapy operation for macular degeneration is a success
February 20, 2019 - Physicians graduated outside the U.S. offer better care for Medicare patients with complex needs
February 20, 2019 - FDA Approves Keytruda (pembrolizumab) for the Adjuvant Treatment of Patients with Melanoma with Involvement of Lymph Node(s) Following Complete Resection
February 20, 2019 - Study identifies brain cells that modulate behavioral response to threats
February 20, 2019 - Researchers take closer look at how viruses bind cells and cause infection
February 20, 2019 - Newly developed gene therapy helps decelerate aging process
February 20, 2019 - Study suggests new treatment strategy for deadly brain cancer
February 20, 2019 - Scientists develop unique hybrid implant that imitates bone structure
February 20, 2019 - Push-ups can be tailored to meet specific needs of individuals
February 20, 2019 - CVD Does Not Modify Depression-Mortality Link in Elderly
February 20, 2019 - Electrical activity early in fruit flies’ brain development could shed light on how neurons wire the brain
February 20, 2019 - Machine learning technique helps predict which asthma patients respond to corticosteroid therapy
February 20, 2019 - Self-reported sleep duration is a useful tool to measure sleep in children, study suggests
February 20, 2019 - T-cells play key role in how the body fights follicular lymphoma
February 20, 2019 - Study shows how 3D organization of genetic material helps perpetuate the species
February 20, 2019 - Researchers engineer stem cell with ‘suicide genes’ to induce cell death in all but beta cells
February 20, 2019 - Study reveals major sex differences in management of cardiovascular risk factors among U.S. adults
February 20, 2019 - Health Tip: Get Your Child to School on Time
February 20, 2019 - Shortcut strategy for screening compounds with clinical potentials for drug development
February 20, 2019 - Common acid reflux drugs tied to elevated risk for kidney disease
February 20, 2019 - Microbiome could be culprit when good drugs do harm
February 20, 2019 - Prenatal exposure to forest fires causes stunted growth in children
February 20, 2019 - Gene therapy restores hearing in mice with congenital genetic deafness
February 20, 2019 - First molecular test predicts treatment response for kidney cancer
February 20, 2019 - New method for improved visualization of single-cell RNA- sequencing data
February 20, 2019 - Researchers capture altered brain activity patterns of Parkinson’s in mice
February 20, 2019 - A possible blood test for detecting Alzheimer’s disease before symptoms show
February 20, 2019 - Primary care physicians associated with longevity, new research finds
February 19, 2019 - New study identifies many key lessons to establish sanctioned safe consumption sites
February 19, 2019 - Single CRISPR treatment can safely and stably correct genetic disease
February 19, 2019 - Multinational initiative to study familial primary distal renal tubular acidosis
February 19, 2019 - Breakthrough study highlights the promise of cell therapies for muscular dystrophy
February 19, 2019 - Subsymptom Threshold Exercise Speeds Concussion Recovery
February 19, 2019 - Midline venous catheters – infants: MedlinePlus Medical Encyclopedia
February 19, 2019 - Searching for side effects
February 19, 2019 - Humanity is all right, probably, although human extinction remains quite possible, researcher says
February 19, 2019 - Having Anesthesia Once as a Baby Does Not Cause Learning Disabilities, New Research Shows
February 19, 2019 - Anti-cancer immunotherapy could be used to fight HIV
February 19, 2019 - Customized Micropatterning for Improved Physiological Relevance
February 19, 2019 - Unique gene therapy approach paves new way to tackle rare, inherited diseases
February 19, 2019 - Activating gene that helps excite neurons reverses depression in male mice
February 19, 2019 - Science Puzzling Out Differences in Gut Bacteria Around the World
February 19, 2019 - Cells that destroy the intestine
February 19, 2019 - On recovery, vulnerability and ritual: An exhibit in white
February 19, 2019 - Scientific Duo Gets Back To Basics To Make Childbirth Safer
February 19, 2019 - COPD patients need more support when understanding new chest symptoms
February 19, 2019 - Using light-based method for production of pharmaceutical molecules
February 19, 2019 - Scientists find link between inflammation and cancer
February 19, 2019 - The High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
February 19, 2019 - Hearing impairment associated with accelerated cognitive decline with age
February 19, 2019 - Researchers identify multiple genetic variants associated with body fat distribution
February 19, 2019 - Influenza and common cold are completely different diseases, study shows
February 19, 2019 - Scientists untangle how microbes manufacture key antibiotic compound
February 19, 2019 - Greater primary care physician supply associated with longer life spans
February 19, 2019 - HIV-1 protein suppresses immune response more broadly than thought
February 19, 2019 - Brain imaging indicates potential success of drug therapy in depressive patients
February 19, 2019 - For 2020 Dem Hopefuls, ‘Medicare-For-All’ Is A Defining Issue, However They Define It
February 19, 2019 - Specialized lung cells appear in the developing fetus much earlier than previously thought
February 19, 2019 - KU professor discusses promise of brain-computer interface to aid, restore communication
February 19, 2019 - Highly effective solution for detecting onset of aggregation in nanoparticles
February 19, 2019 - Early marker of cardiac damage triggered by cancer treatment identified
February 19, 2019 - Antidepressant drug could save people from deadly sepsis, research suggests
February 19, 2019 - CRISPR technology creates pluripotent stem cells that are ‘invisible’ to the immune system
February 19, 2019 - New study establishes how stress favors breast cancer growth and spread
February 19, 2019 - Midlife Systemic Inflammation Linked to Later Cognitive Decline
February 19, 2019 - Therapy derived from parasitic worms downregulates proinflammatory pathways
February 19, 2019 - Antimicrobial reusable coffee cups are less likely to become contaminated with bacteria, study shows
February 19, 2019 - Harnessing the evolutionary games played by cancer cells to advance therapies
February 19, 2019 - AHA News: Heart Transplant Survivor Gets Wedding Proposal at Finish Line
February 19, 2019 - HIV hidden in patients’ cells can now be accurately measured
February 19, 2019 - Research finds reasons for sudden cardiac death in patients with stable ischemic disease
February 19, 2019 - New protocol could help physicians to rule out bacterial infections in infants
February 19, 2019 - Women experiencing miscarriage should be offered treatment choices
February 19, 2019 - New protocol can help identify febrile infants at low risk for serious bacterial infections
Researchers aim to develop a functional cure for HIV using therapeutic vaccines

Researchers aim to develop a functional cure for HIV using therapeutic vaccines

image_pdfDownload PDFimage_print

EU-funded researchers are leading efforts to develop a functional cure for HIV using innovative therapeutic vaccines to halt the progression of the devastating virus, increase the availability and affordability of treatment, and improve patients’ quality of life.

The approach, which has undergone promising proof-of-concept preclinical and clinical trials in the EU-funded IHIVARNA project and is being investigated further in the HIVACAR initiative – also funded by the EU – marks a significant advance in preventive and therapeutic efforts to tackle the HIV epidemic worldwide.

‘The aim is to achieve a functional cure for HIV. No therapeutic vaccine or drug combination has achieved this goal. Therefore expectations are very high,’ says Felipe García, the coordinator of both projects at Spanish research institute IDIBAPS.

A functional cure would mean the immunodeficiency virus goes into remission, infected cells cease to replicate and the patient’s viral load is maintained at undetectable levels, preventing the onset of AIDS and other co-occurring diseases.

Although it would not eradicate HIV infection, an effective therapeutic vaccine would enable patients to live an almost normal life, less reliant on taking a daily cocktail of antiretroviral drugs in order to keep the disease under control. And while prevention measures would still be necessary, the risk of transmission to other people would be minimised, helping to halt the spread of HIV.

Vaccines on trial

In the IHIVARNA project, the researchers made important progress toward achieving that goal, using rational design techniques to develop immunogens – proteins encoded with mRNA messenger molecules capable of eliciting an immune response to HIV-1, the most widespread form of the virus.

Successful preclinical and toxicological tests enabled the team to obtain regulatory approval for a proof-of-concept candidate vaccine, leading to phase I and phase II clinical trials, including a first-in-human dose-escalating trial with HIV-infected individuals.

‘Overall, the vaccine was safe and well tolerated. It was able to induce moderate HIV-specific immune responses in the phase I clinical trial. Additional results from the phase II clinical trial are being analysed,’ García says.

In the follow-up project HIVACAR, the researchers are planning to administer therapeutic vaccines customised for each patient, alongside a potent antibody able to neutralise the binding of the virus to infected cells and a latency reversing agent, a molecule capable of unmasking the virus.

‘Using a computer-simulation-assisted drug-development technique, we have sequenced HIV-1 from four patients and have prepared four personalised vaccines that will initially be tested in animal models. Clinical trials will subsequently be conducted with a number of HIV patients in five hospitals in four European countries,’ García says. ‘The final objective is to be able to offer an alternative to current combined antiretroviral therapy for HIV-1 infected patients, although as these are proof-of-concept trials more research and further studies will be needed to confirm the results.’

Urgently seeking new strategies

A therapeutic vaccine capable of achieving a functional cure would have an enormous impact on the lives of HIV patients, who are currently reliant on taking regular doses of antiretroviral drugs for life in order to suppress the disease, often with significant side effects.

Although combined life-long antiretroviral therapy (cART) has proven highly effective in preventing disease progression and death, it has a number of public health, economic and clinical limitations. Standard cART does not fully restore health or a normal immune status in HIV-infected individuals, and patients still experience co-morbidities such as cardiovascular disease, bone disorders and cognitive impairment.

Moreover, access to treatment and the cost of the drugs is an impediment in many areas of the world, especially in developing countries which are home to a majority of the 37 million HIV patients globally. Despite improved awareness, prevention measures and more effective treatments, 2 million people still become infected with HIV worldwide each year.

‘These factors underscore the urgent need for new preventive and therapeutic strategies to be developed and tested,’ García says.

Source:

http://ec.europa.eu/research/infocentre/printversion_en.cfm?id=/research/headlines/news/article_18_11_29-1_en.html?infocentre&item=Infocentre&artid=49807

Tagged with:

About author

Related Articles